CureVac
Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.
Rate
About
CureVac is a biopharmaceutical company focused on developing and commercializing novel mRNA-based vaccines and therapeutics. Their technology platform enables the development of treatments for a range of diseases, including infectious diseases and cancer, by leveraging the body's own cells to produce therapeutic proteins.
Technology stack
detected 2026-06-24Est. monthly stack spend~$140/mo
Email
Microsoft 365
Hosting
Hetzner
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does CureVac do?
CureVac is a biopharmaceutical company focused on developing and commercializing novel mRNA-based vaccines and therapeutics. Their technology platform enables the development of treatments for a range of diseases, including infectious diseases and cancer, by leveraging the body's own cells to produce therapeutic proteins.
How much funding has CureVac raised?
CureVac has raised a total of $2.1B in funding. The most recent round on record is IPO.
Where is CureVac headquartered?
CureVac is headquartered in Tübingen, Germany.
When was CureVac founded?
CureVac was founded in 2000.
What industry does CureVac operate in?
CureVac operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Vaccines.